Home / Biosimilars
Biosimilars
News![]() The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 11 December 2020 tha... ![]() Canadian pharmaceuticals firm Valeo Pharma (Valeo) announced on 9 December 2020 that Canada’s drug regulator, Health Canada,... ![]() The European Commission (EC) has granted marketing authorization for the pegfilgrastim biosimilar Nyvepria (PF-06881894), dev... ![]() Iceland-based biopharmaceutical company Alvotech announced on 19 November 2020 that its US subsidiary, Alvotech USA... ![]() China-based drugmaker Shanghai Henlius Biotech (Henlius) announced on 7 December 2020 that China’s National Medical Products... |
Research![]() The results of a survey carried out by the World Health Organization (WHO) in 2019‒2020 [1] revealed that, despite the effort... ![]() The vital contribution of Health Technology Assessment (HTA) is well recognized and consolidated in scientific and technologi... ![]() A survey was carried out by the World Health Organization (WHO) in 2019‒2020 covering most current topics pertinent to biosim... ![]() In Europe, the individual Member States are responsible for designing policies that regulate the market entry and use of phar... ![]() China-based drugmaker Innovent Biologics (Innovent) announced on 23 November 2020 positive results for its copy bevacizumab b... |
General![]() Korea-based Samsung Bioepis (Samsung and Biogen’s joint venture) has initiated phase III trials for its denosumab biosimilar,... ![]() Last update: 22 January 2021Filgrastim is a granulocyte colony-stimulating factor (G-CSF). Filgrastim treatment can be u... ![]() The European Medicines Agency (EMA) is the body responsible for approval of biosimilars within the European Union (EU). A leg... ![]() Last update: 15 January 2021Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating fa... ![]() Last update: 15 January 2021Trastuzumab is a monoclonal antibody that binds to and inactivates the human epidermal growt... |
Generics News Research General
- Generics applications under review by EMA – Jan...Generics/General | Posted 22/01/2021
- Perspectives of prescribing practices in public...Generics/Research | Posted 15/01/2021
- A European pharmaceutical strategy promoting ge...Generics/General | Posted 08/01/2021
- Familiarity with substitution of prescription g...Generics/Research | Posted 11/12/2020
Biosimilars News Research General
- Samsung biosimilars: denosumab clinical trials...Biosimilars/General | Posted 22/01/2021
- Biosimilars of filgrastimBiosimilars/General | Posted 20/03/2015
- EMA recommends approval of adalimumab and insul...Biosimilars/News | Posted 22/01/2021
- Biosimilars and lack of resourcesBiosimilars/Research | Posted 22/01/2021